4-THIO SUBSTITUTED QUINOLINE AND NAPHTHYRIDINE COMPOUNDS
申请人:Xtl Biopharmaceuticals Ltd.
公开号:EP2061466A2
公开(公告)日:2009-05-27
US8143276B2
申请人:——
公开号:US8143276B2
公开(公告)日:2012-03-27
[EN] 4-THIO SUBSTITUTED QUINOLINE AND NAPHTHYRIDINE COMPOUNDS<br/>[FR] COMPOSÉS À BASE DE QUINOLÉINE ET DE NAPHTYRIDINE À SUBSTITUTION THIO EN POSITION 4
申请人:XTL BIOPHARMACEUTICALS LTD
公开号:WO2008024423A2
公开(公告)日:2008-02-28
[EN] The present invention relates to 4-thio substituted quinoline and naphthyridine derivatives and processes for their preparation. The invention also related to methods for treating infection of Hepatitis C virus by administering a 4-thio substituted quinoline or naphthyridine derivative. [FR] La présente invention concerne des derivés de quinoléine et de naphtyridine à substitution thio en position 4 et leurs procédés de préparation. L'invention concerne également des procédés de traitement d'infection du virus de l'hépatite C par l'administration de dérivé de quinoléine et de naphtyridine à substitution thio en position 4.
4-thio substituted quinoline and naphthyridine compounds
申请人:Yang Zhen
公开号:US20090054477A1
公开(公告)日:2009-02-26
The present invention relates to 4-thio substituted quinoline and naphthyridine derivatives and processes for their preparation. The invention also related to methods for treating infection of Hepatitis C virus by administering a 4-thio substituted quinoline or naphthyridine derivative.